Literature DB >> 6157736

Biochemical characterization of Ia antigens. I. Characterization of the 31K polypeptide associated with I-A subregion Ia antigens.

J P Moosic, A Nilson, G J Hämmerling, D J McKean.   

Abstract

Procedures are presented for the preparative isolation of murine Ia antigens directly from splenocyte detergent extracts with monoclonal immunoadsorbents. Utilizing these procedures, three Ia (I-A subregion) polypeptides (alpha, 31K, beta) were isolated and their m.w. and pI values characterized. Evidence is presented that indicates that: 1) the 31K polypeptide probably does not associate with the Ia alpha and beta chain complex during the Ia isolation procedure; 2) the 31K polypeptide is not tightly bound to the alpha/beta Ia complex and can be selectively removed by freezing and thawing and by washing the Ia-immunoadsorbent with buffers containing pyrrolidinone (a polar solvent); and (3) unlike the alpha and beta chains, the 31K polypeptide is not intrinsically radiolabeled with 3H fucose and 3H glucosamine, indicating that the 31K polypeptide either contains a carbohydrate structure that is different from that of the alpha and beta chains or it is not a glycopeptide. These data suggest that although Ia antigens are probably comprised of three polypeptides in the intact cell, only two (alpha and beta) are required to maintain alloantigenic determinants.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6157736

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  A biochemical analysis of Ak molecules from mutant antigen presenting cell lines.

Authors:  S Chatterjee-Das; G G Schlauder; D H Sachs; L H Glimcher; W E Paul; D J McKean
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

2.  Hybrid (combinatorial) Ia specificities: gene complementations to generate Ia.22.

Authors:  W P Lafuse; J F McCormick; P S Corser; C S David
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

3.  Control of HLA-DR antigen gene expression at the pretranslational level: comparison of an HLA-DR-positive B lymphoblastoid cell line and its HLA-DR-negative variant.

Authors:  S Loosmore; P Gladstone; D Pious; L M Jerry; T Tamaoki
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

4.  Tryptic peptide comparison of Ia antigen alpha and beta polypeptides from the I-A mutant B6.C-H-2bm12 and its congenic parental strain B6.

Authors:  D J McKean; R W Melvold; C David
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

5.  Monensin prevents terminal glycosylation of the N- and O-linked oligosaccharides of the HLA-DR-associated invariant chain and inhibits its dissociation from the alpha-beta chain complex.

Authors:  C E Machamer; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

6.  Isolation and partial characterization of Fc gamma-binding proteins of human leukocytes.

Authors:  A Kulczycki; L Solanki; L Cohen
Journal:  J Clin Invest       Date:  1981-12       Impact factor: 14.808

7.  Structure of the murine Ia-associated invariant (Ii) chain as deduced from a cDNA clone.

Authors:  P A Singer; W Lauer; Z Dembić; W E Mayer; J Lipp; N Koch; G Hämmerling; J Klein; B Dobberstein
Journal:  EMBO J       Date:  1984-04       Impact factor: 11.598

8.  Regulation of MHC class II invariant chain expression: induction of synthesis in human and murine plasmocytoma cells by arresting replication.

Authors:  H J Rahmsdorf; N Koch; U Mallick; P Herrlich
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

9.  Structure of murine Ia antigens. Two dimensional electrophoretic analyses and high pressure liquid chromatography tryptic peptide maps of products of the I-A and I-E subregions and of an associated invariant polypeptide.

Authors:  M McMillan; J A Frelinger; P P Jones; D B Murphy; H O McDevitt; L Hood
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

10.  Human Ia beta chains and the invariant chain share a common antigenic determinant.

Authors:  O J Finn; C J Stackhouse; R S Metzgar
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.